Novacyt SA ALNOV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.84
- Day Range
- €0.79–0.84
- 52-Week Range
- €0.42–1.00
- Bid/Ask
- €0.79 / €0.82
- Market Cap
- €55.58 Mil
- Volume/Avg
- 304,028 / 187,828
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.54
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.06%
Company Profile
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 222
- Website
- https://www.novacyt.com
Valuation
|
Metric
|
ALNOV
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.48 |
Price/Sales | 6.54 |
Price/Cash Flow | — |
Price/Earnings
ALNOV
Financial Strength
|
Metric
|
ALNOV
|
|---|---|
Quick Ratio | 4.91 |
Current Ratio | 5.09 |
Interest Coverage | −48.12 |
Quick Ratio
ALNOV
Profitability
|
Metric
|
ALNOV
|
|---|---|
Return on Assets (Normalized) | −12.04% |
Return on Equity (Normalized) | −14.88% |
Return on Invested Capital (Normalized) | −15.54% |
Return on Assets
ALNOV
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Krdpsdrj | Sxsqyk | $184.2 Bil | |
SYK
| Stryker Corp | Ycnyhnqs | Qldc | $125.1 Bil | |
MDT
| Medtronic PLC | Rrkfssjtw | Gtcts | $108.5 Bil | |
BSX
| Boston Scientific Corp | Vldzxnf | Pxjrbq | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Htfdyrcxll | Swfnb | $51.4 Bil | |
DXCM
| DexCom Inc | Jczdgmvwv | Rjpq | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Zcfkmznkj | Wpgpq | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Tmcstwkv | Zsprt | $24.4 Bil | |
ALGN
| Align Technology Inc | Rwfmrhf | Tdffy | $21.7 Bil | |
PODD
| Insulet Corp | Hhljxfjfd | Kxvpxyd | $12.2 Bil |